BofA Securities analyst Wamsi Mohan maintains Buy rating for IBM with $320 price target, citing transformational initiatives, ...

The U.S. Department of Justice has filed a civil forfeiture complaint seeking to claim more than $225 million in ...

Rocket Lab Corp (NASDAQ:RKLB) shares are up about 7% over the past month. Here's a look at why the stock has captured ...

European shares were mixed today. The eurozone's STOXX 600 declined 0.4%, while Spain's IBEX 35 Index rose 0.1%. London's ...

KWESST shares are skyrocketing after the company secured a major defense order for its advanced battlefield laser detection ...

Cava Group has a lower P/E than the aggregate P/E of 65.54 of the Hotels, Restaurants & Leisure industry. Ideally, one might ...

Stephanie Link of Hightower said Uber Technologies is her final trade. Brian Belski at BMO Capital Markets picked The ...

U.S. stocks inched higher by midday Wednesday, as traders weighed geopolitical uncertainty and awaited the Federal Reserve's ...

CMG's sales weakness is due to industry challenges, but with a plan to boost traffic and loyalty program, analyst maintains a ...

AbbVie's atogepant showed fewer side effects and greater efficacy than topiramate in a Phase 3 migraine prevention trial.

Shares of Valero are overbought and trading at resistance. This means there is a good chance they reverse and head lower.

According to Benzinga Pro, Encompass Health's peer group average for short interest as a percentage of float is 5.19%, which ...